Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 274-950-1 | CAS number: 70865-20-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- May 2000
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 000
- Report date:
- 2000
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.5100 - Bacterial Reverse Mutation Test (August 1998)
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- Sodium 4-[[4-[(4-hydroxy-2-methylphenyl)azo]phenyl]amino]-3-nitrobenzenesulphonate
- EC Number:
- 274-950-1
- EC Name:
- Sodium 4-[[4-[(4-hydroxy-2-methylphenyl)azo]phenyl]amino]-3-nitrobenzenesulphonate
- Cas Number:
- 70865-20-2
- Molecular formula:
- C19H16N4O6S.Na
- IUPAC Name:
- sodium 4-[[4-[(4-hydroxy-2-methylphenyl)azo]phenyl]amino]-3-nitrobenzenesulphonate
- Test material form:
- solid: particulate/powder
- Details on test material:
- Acid Yellow 199
Constituent 1
Method
Species / strain
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9 mix from rat liver and S9 mix from hamster liver
- Test concentrations with justification for top dose:
- Test groups
first plate incorporation test:
with (10% rat liver) and without metabolic activation: 50, 160, 500, 1600 and 5000 µg/plate
second plate incorporation test:
without metabolic activation: 0.5, 1.6, 5, 16, 50 and 160 µg/plate (TA 100 and TA 1535)
1.6, 5, 16, 50, 160 and 500 µg/plate (TA 1537 and TA 98)
preincubation test:
without metabolic activation:
0.05, 0.16, 0.5, 1.6, 5 and 16 µg/plate (TA 100)
0.5, 1.6, 5, 16, 50 and 160 µg/plate (TA 1535)
0.16, 0.5, 1.6, 5, 16, 50, 160 and 500 µg/plate (TA 1537)
1.6, 5, 16, 50, 160 and 500 µg/plate (TA 98)
50, 160, 500, 1600 and 5000 µg/plate (WP2uvrA)
with metabolic activation (30 % Syrian golden hamster liver):
1.6, 5, 16, 50, 160 and 500 µg/plate (TA 100 and TA 1535
5, 16, 50, 160, 500 and 1600 µg/plate (TA 1537)
5, 16, 50, 160, 500, 1000 and 1600 µg/plate (TA 98)
50, 160, 500, 1600 and 5000 µg/plate (WP2uvrA)
repeat preincubation test:
without metabolic activation:
0.5, 1.6, 2.5, 5, 10, 16 and 50 µg/plate (TA 1537)
with metabolic activation (30 % Syrian golden hamster liver):
160, 250, 500, 650, 800 and 1000 µg/plate (TA 98)
Control groups
negative controls:
a: untreated control
b: solvent controls (0 µg/plate)
positive controls:
a: without metabolic activation:
sodium-azide for strain TA 100 and TA 1535
9-aminoacridine for strain TA 1537
2-nitrofluorene for strain TA 98
4-nitroquinoline-N-oxide for strain WP2uvrA
b: with metabolic activation (10% rat liver): 2-aminoanthracene for all tester strains
c: with metabolic activation (30% Syrian golden hamster liver and preincubation):
2-aminoanthracene for strain TA 100, TA 1535, TA 1537 and WP2uvrA
congo red for strain TA 98 - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO
- Justification for choice of solvent/vehicle: solubitiy in water is not sufficient
- Formulation: suspended in DMSO at appropriate concentrations immediately before use
Controlsopen allclose all
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- Positive controls:
- yes
- Positive control substance:
- 4-nitroquinoline-N-oxide
- 9-aminoacridine
- 2-nitrofluorene
- sodium azide
- Remarks:
- without metabolic activation
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- Positive controls:
- yes
- Positive control substance:
- congo red
- other: 2-aminoanthracene
- Remarks:
- with metabolic activation
- Details on test system and experimental conditions:
- Source of bacteria: stock cultures in the bank of "Genetic Toxicology", HMR Deutschland GmbH, ProTox, prepared from the original bacterial strains
Test organisms: Salmonella typhimurium strains
TA 98 hisD3052 rfa uvrB +R,
TA 100 hisG46 rfa uvrB +R,
TA 1535 hisG46 rfa uvrB,
TA 1537 hisC3076 rfa uvrB
and
E. coli WP2 uvrA pKM101
Experimental conditions in vitro: approx. 37°C in an incubator
Two independent mutation tests were performed unless clearly positive or dose-related activity was observed in the first test. Where results were negative or equivocal, a second test was conducted. This included a pre-incubation step if the first test was clearly negative. Pre-incubation involved incubating the test substance, S9-mix and bacteria for a short period before pouring this mixture onto plates of minimal agar.
Each test was performed in both the presence and absence of S9-mix using all bacterial tester strains and a range of concentrations of the test substance. Positive and negative controls as well as solvent controls were included in each test. Triplicate plates were used.
The highest concentration in the first mutation experiment was usually 50 mg/ml of the test substance in the chosen solvent, which provided a final concentration of 5000 µg/plate. Further dilutions of 1600, 500, 160 and 50 µg/plate were used. Suitable dose levels used in the second experiment may be different depending on any toxicity seen in the first experiment. A reduction in the number of spontaneously occurring colonies and visible thinning of the bacterial lawn were used as toxicity indicators.
Thinning of the bacterial lawn was evaluated microscopically.
In both tests top agar was prepared which, for the Salmonella strains, contained 100 ml agar (0.6 % (w/v) agar, 0.5 % (w/v) NaCI) with 10 ml of a 0.5 mM histidine-biotin solution. For E. coli histidine was replaced by tryptophan (2.5 ml, 0.5 mM). The following ingredients were added (in the following order) to 2 ml of molten top agar at approx. 48°C:
0.5 ml S9-mix (if required) or buffer
0.1 ml of an overnight nutrient broth culture of the bacterial tester strain
0.1 ml test compound solution (dissolved in deionized water)
In the second mutagenicity test if appropriate these top-agar ingredients were preincubated by shaking for approximately 30 minutes at approx. 30 DC and the top agar composition as described was added accordingly.
After mixing, and pre-incubation if appropriate, the liqUid was poured into a petri dish containing a 25, mllayer of minimal agar (1.5 % (w/v) agar, Vogel-Bonner E medium with 2 % (w/v) glucose). After incubation for approximately 48 hours at approx. 37°C in the dark, colonies (his+ and trp+ revertants) were counted by hand or by a suitable automatic colony counter.
The counter was calibrated for each test by reading a test pattern plate to verify the manufacturer's requirements for the counter's sensitiveness. - Evaluation criteria:
- Criteria for a valid assay
- the solvent control data are within the laboratory's normal control range for the spontaneous mutant frequency
- the positive controls induce increases in the mutation frequency which are significant and within the laboratory's normal range
Criteria for a positive response
a) it produces at least a 2-fold increase in the mean number of revertants per plate of at least one of the tester strains over the mean number of revertants per plate of the appropriate vehicle control at complete bacterial background lawn
b) it induces a dose-related increase in the mean number of revertants per plate of at least one of the tester strains over the mean number of revertants per plate of the appropriate vehicle control in at least two to three concentrations of the test compound at complete bacterial background lawn.
If the test substance does not achieve either of the above criteria, it is considered to show no evidence of mutagenic activity in this system.
Results and discussion
Test results
- Species / strain:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- Sterility checks and control plates
Sterility of S9-mix and the test compound were indicated by the absence of contamination on the test material and S9-mix sterility check plates. Control plates (background control and positive controls) gave the expected number of colonies, i.e. values were within the laboratory's historical control range.
Solubility and toxicity
The test compound was suspended in DMSO and a stock solution of 50 mg/ml was prepared for the highest concentration, which provided a final concentration of 5000 µg/plate. Further dilutions of 1600, 500, 160 and 50 µg/plate were used in the plate incorporation test.
Visible precipitation of the test compound on the plates was observed at 5000 µg/plate.
The top dose level for each bacterial strain in the third experiment was selected on the basis of the first and second mutation experiments results.
In the plate incorporation test dose-related toxicity was observed to the Salmonella strains at concentrations of 500 µg/plate and above in the presence of metabolic activation with the tester strains TA 100 and TA 1535, and at 1600 µg/plate and above with the strains TA 1537 and TA 98.
In the absence of metabolic activation, toxicity was observed at concentrations of 5 µg/plate and greater (TA 100), at 160 µg/plate (TA 1535) and at 500 µg/plate (TA 1537 and TA 98).
In the preincubation test dose-related toxicity was observed at concentrations of 500 µg/plate in the presence of metabolic activation with the tester strains TA 100 and TA 1535, and at 1600 µg/plate with the strains TA 1537 and TA 98.
In the absence of hamster liver metabolic activation, toxicity was observed at concentrations of 5 µg/plate and greater (TA 100), at 160 µg/plate (TA 1535) and at 10 µg/plate and greater (TA 1537), at 500 µg/plate (TA 98).
Thinning of bacterial lawns and in most cases also a reduction in the number of colonies were observed at these dose levels.
Mutagenicity
In both independent mutation tests, Acid Yellow 199 was tested for mutagenicity with the same concentrations as described in section 6.2. The number of colonies per plate with each strain as well as mean values of 3 plates are given.
Plate incorporation test:
The test compound did not cause a significant increase in the number of revertant colonies at any dose level with any of the tester strains either in the absence or presence of rat liver S9-mix in either mutation test. No dose-dependent effect was obtained.
Preincubation test: In the presence of hamster liver S9-mix (30 % (v/v)) using the preincubation method according to Prival the test compound did not cause a significant increase in the number of revertant colonies under the experimental conditions described.
A small increase in the number of revertant colonies was obtained of the tester strain TA 1537 in the absence of exogenous metabolic activation and of the tester strain TA 98 in the presence of exogenous metabolic activation.
In a repeat experiment, these results have not been confirmed.
All positive controls produced significant increases in the number of revertant colonies. Thus, the sensitivity of the assay and the efficacy of the exogenous metabolic activation system were demonstrated.
Applicant's summary and conclusion
- Conclusions:
- Acid Yellow 199 is not mutagenic in the standard plate test (plate incorporation test) or in the preincubation method according to Prival
- Executive summary:
Acid Yellow 199 was tested for mutagenicity with the strains TA 100, TA 1535, TA 1537 and TA 98 of Salmonella typhimurium and with Escherichia coli WP2uvrA.
Two independent mutagenicity studies were conducted, one as the standard plate test with the plate incorporation method and the other as a modified preincubation test (Prival test). The studies were performed in the absence and in the presence of a metabolizing system derived from a rat liver homogenate or a hamster liver homogenate. For all studies, the compound was suspended in DMSO, and each bacterial strain was exposed to 5 and 6 dose levels in the plate incorporation test. In the preincubation test each bacterial strain was exposed to 6 and 8 dose levels.
Doses for the plate incorporation test ranged from 50 to 5000µg/plate.
Because of high toxicity the plate incorporation test was repeated with the strains TA100, TA 1535, TA 1537 and TA 98 in the absence of metabolic activation.
Low dose levels ranged from 0.5 to 160µg/plate, and high dose levels ranged from 1.6to 500µg/plate.
Dose ranges for the preincubation study were variable across bacterial strains to account for varying toxicity effects: low dose levels ranged from 0.05 to16µg/plate, and high dose levels ranged from 50 to 5000µg/plate.
A repeat test was performed with the strains TA 1537 without metabolic activation and TA 98 with metabolic activation in order to confirman increase in the number of mutant colonies.
Doses ranged from 0.5 to 50µg/platefor strain TA 1537 and from 160 to1000µg/platefor strain TA 98.
Control plates without mutagen showed that the number of spontaneous revertant colonies was within the laboratory's historical control. All positive control compounds gave the expected increase in the number of revertant colonies.
Visible precipitation of the test compoundon the plates was observed at 5000µg/plate.
In the plate incorporation test dose-related toxicity was observed to the Salmonella strains at concentrations of 500µg/plateand above in the presence of metabolic activation with the tester strains TA 100 and TA 1535, and at 1600µg/plateand abovewith the strains TA 1537 and TA 98.
In the absence of metabolic activation, toxicity was observed at concentrations of5µg/plateand greater (TA 100), at 160µg/plateand greater (TA 1535) and at500µg/plateand greater (TA 1537 and TA 98).
In the preincubation test dose-related toxicity was observed at concentrations of500µg/platein the presence of metabolic activation with the tester strains TA 100 and TA 1535, and at 1600µg/platewith the strain TA 1537 and TA 98.
In the absence of hamster liver metabolic activation, toxicity was observed atconcentrations of 5µg/plate and greater (TA 100), at 160µg/plate(TA 1535), at10µg/plateand greater (TA 1537), and at 500µg/plate (TA 98).
Thinning of bacterial Iawns and in most cases also a reduction in the number of colonies were observed at these doselevels.
Plate incorporation test
Mutagenicity: In the absence of the metabolic activation system the test compound did not result in relevant increases in the number of revertants in any of the bacterial strains. Also in the presence of rat liver activation system (10 % (v/v)), treatment of the cells withAcid Yellow 199did not result in relevant increases in the number of revertant colonies.
Preincubation test:
In the absence and in the presence of hamster liver S9-mix (30 % (v/v)) using the preincubation method according toPrivalAcid Yellow 199 did not result in relevant increases in the number of revertant colonies with any of the tester strains.
Summarizing, it can be stated that Acid Yellow 199is not mutagenic in the standard plate test (Ames Test) and in the preincubation method according to Privat at the dose levels investigated.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)